全文获取类型
收费全文 | 15062篇 |
免费 | 1703篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 194篇 |
儿科学 | 439篇 |
妇产科学 | 597篇 |
基础医学 | 1864篇 |
口腔科学 | 447篇 |
临床医学 | 2289篇 |
内科学 | 2628篇 |
皮肤病学 | 167篇 |
神经病学 | 1116篇 |
特种医学 | 688篇 |
外国民族医学 | 1篇 |
外科学 | 2209篇 |
综合类 | 378篇 |
一般理论 | 19篇 |
预防医学 | 1533篇 |
眼科学 | 342篇 |
药学 | 965篇 |
中国医学 | 14篇 |
肿瘤学 | 903篇 |
出版年
2021年 | 182篇 |
2020年 | 159篇 |
2019年 | 231篇 |
2018年 | 304篇 |
2017年 | 295篇 |
2016年 | 277篇 |
2015年 | 336篇 |
2014年 | 390篇 |
2013年 | 555篇 |
2012年 | 645篇 |
2011年 | 679篇 |
2010年 | 501篇 |
2009年 | 452篇 |
2008年 | 633篇 |
2007年 | 655篇 |
2006年 | 596篇 |
2005年 | 603篇 |
2004年 | 626篇 |
2003年 | 630篇 |
2002年 | 564篇 |
2001年 | 419篇 |
2000年 | 406篇 |
1999年 | 402篇 |
1998年 | 254篇 |
1997年 | 272篇 |
1996年 | 223篇 |
1995年 | 210篇 |
1994年 | 161篇 |
1993年 | 167篇 |
1992年 | 271篇 |
1991年 | 271篇 |
1990年 | 272篇 |
1989年 | 266篇 |
1988年 | 245篇 |
1987年 | 192篇 |
1986年 | 258篇 |
1985年 | 217篇 |
1984年 | 174篇 |
1983年 | 177篇 |
1982年 | 141篇 |
1981年 | 123篇 |
1980年 | 146篇 |
1979年 | 168篇 |
1978年 | 157篇 |
1977年 | 152篇 |
1976年 | 123篇 |
1975年 | 148篇 |
1974年 | 144篇 |
1973年 | 147篇 |
1972年 | 111篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
E. Niclas Jonsson Rujia Xie Scott F. Marshall Rosalin H. Arends 《British journal of clinical pharmacology》2016,81(4):688-699
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V
1), peripheral volume (V
2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V
1, V
2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V
1 and V
2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit. 相似文献
3.
4.
5.
6.
D Van Neste† RM Trüeb‡ 《Journal of the European Academy of Dermatology and Venereology》2006,20(5):578-583
BACKGROUND: Computer-assisted image analysis has been proposed for human hair growth studies. METHODS: The performances of Trichoscan, a commercially available automated system combining epiluminiscence microscopy with digital image analysis, developed for office-based hair growth measurements, have been evaluated comparatively on the same skin sites using standardized photographic equipment and calibrated processing for contrast-enhanced phototrichogram (CE-PTG) analysis. This reference method has been validated with scalp biopsies and histological examination of serial sectioning. RESULTS: Besides edge effects, hair fibres escaped the Trichoscan analysis for various reasons including, but not limited to, thickness, pigmentation, closeness and crossing. CONCLUSION: Most of these problems have been identified in the late 1980s and remain largely unsolved by the processing software that was evaluated in 2004. Therefore claims promoting the Trichoscan method for accurate hair measurements in clinical trials on scalp and body hair are not supported by the present investigation. The speed at which the analysis is performed is outweighed by the errors in signal detection. Therefore we suggest that improvements must be clearly documented before Trichoscan is established for quantified diagnostic purposes and detailed hair cycle monitoring during hair trials. 相似文献
7.
8.
9.
10.